The C-type lectin dendritic-cell specific ICAM-3 grabbing non-integrin (DC-SIGN) is the major receptor on dendritic cells (DCs) for mycobacteria of the Mycobacterium tuberculosis complex. Recently, we have shown that although the mannose caps of the mycobacterial surface glycolipid lipoarabinomannan (ManLAM) are essential for the binding to DC-SIGN, genetic removal of these caps did not diminish the interaction of whole mycobacteria with DC-SIGN and DCs. Here we investigated the role of the structurally related glycolipids phosphatidylinositol mannosides (PIM) as possible ligands for DC-SIGN. In a binding assay with both synthetic and natural PIMs, DC-SIGN exhibited a high affinity for hexamannosylated PIM 6 , which contains terminal α(1→2)-linked mannosyl residues identical to the mannose cap on ManLAM, but not for di-and tetra-mannosylated PIM 2 and PIM 4 , respectively. To determine the role of PIM 6 in the binding of whole mycobacteria to DC-SIGN, a mutant strain of M. bovis bacillus Calmette-Guérin (BCG) deficient in the production of PIM 6 (ΔpimE) was created, as well as a double knockout deficient in the production of both PIM 6 and the mannose caps on LAM (ΔpimEΔcapA). Compared to the wild-type strain, both mutant strains bound similarly well to DC-SIGN and DCs. Furthermore, the wild-type and mutant strains induced comparable levels of interleukin-10 and interleukin-12p40 when used to stimulate DCs. Hence, we conclude that, like ManLAM, PIM 6 represents a bona fide DC-SIGN ligand, but that other, as-yet unknown-ligands, dominate in the interaction between mycobacteria and DCs.
range from one to six, as is denoted by the subscript to PIM (PIM 1 to PIM 6 ), with triand tetra-acylated PIM 2 and PIM 6 as the predominant species (48) . LAM and PIMs share the initial steps of their biosynthesis (40) , with PIM 4 as the assumed branching point (11, 43) . It is noteworthy that the α(1→2)-linkage, which is only present between the terminal mannosyl residues of the polar PIMs, i.e. PIM 5 and PIM 6 , is identical to the linkage between the terminal mannosyl residues in the mannose caps of LAM ( Figure 1 ). Previous studies have shown that DC-SIGN recognizes α(1→2)-linked dimannosyl and trimannosyl structures with the affinity increasing with length (20, 42, 61) . Furthermore, PIMs are present in the outermost layer of the mycobacterial cell envelope (54) , where they function as adhesins for mycobacterial binding to both macrophages as well as non-phagocytic cells (36, 47, 71) . These observations suggest that PIMs may be involved in the interaction between mycobacteria and DC-SIGN.
In this study, we investigated the role of PIMs in the interaction between mycobacteria and DC-SIGN. We first determined the ability of DC-SIGN to interact with distinct species of PIMs using both natural and synthetic PIMs (natPIMs and synPIMs, respectively). We found that DC-SIGN exhibited a high affinity for the polar PIM 6 , yet binding to the apolar, less mannosylated PIMs, i.e. PIM 2 and PIM 4 , could not be observed. The next step was to further clarify the role of PIMs in the binding of mycobacteria to DC-SIGN. The enzyme catalyzing the transfer of the fifth mannose to PIM 4 to produce PIM 5 is PimE (gene Rv1159) (49) , thus a mutant strain of M. bovis Figure 1 . Structure of the synthetic PIM 6 . PIM 6 consist of a GPI anchor mannosylated with six mannosyl residues. Natural PIMs can be further acylated at the mannosyl group attached to the C2-position of the inositol ring (Ac 1 PIMs) and subsequently at the C3-position of inositol itself (Ac 2 PIMs). PIM 4 consists of a GPI anchor with four mannosyl residues in which the three mannosyl residues extending from the C6-position of the inositol ring are linked in α(1→6)-configuration. The terminal mannosyl residue in PIM 4 is substituted by two α(1→2)-linked mannosyl residues to form PIM 6 . This part of PIM 6 is identical to the α(1→2)-linked mannosyl residues in the mannose cap on ManLAM. phosphatiDyliNositol maNNosiDes iN MyCobACTerIuM-host iNteractioN 5 BCG (ΔpimE) that expresses PIM 2 and PIM 4 , but not of PIM 6 was created. To overcome the possibility of redundancy between ligands for DC-SIGN, we also constructed a double mutant devoid of both PIM 6 and the mannose caps on LAM (ΔpimEΔcapA). Unexpectedly, both mutant strains bound similarly well to both DC-SIGN and DCs as compared to the wild-type strain. Furthermore, when the wild-type and mutant strains were used to stimulate DCs, we did not find indications of a different skewing (IL-12p40/IL-10 ratio) of the immune response between the strains. Hence, we conclude that although PIM 6 is a ligand for DC-SIGN, its role in the interaction between mycobacteria and DC-SIGN, like that for the mannose caps on LAM, is limited. Binding of the mutant strains to DC-SIGN and DCs could still be blocked by mannan and antibodies against DC-SIGN, suggesting that other, as-yet-unknown, ligands for DC-SIGN must be present on the mycobacterial cell surface.
methodS bacterial strains and growth conditions
M. bovis BCG strain Copenhagen (8) was grown in Middlebrook 7H9 broth (Difco) with 10% Middlebrook albumin/dextrose/catalase (ADC) enrichment (BBL) and 0.05% Tween-80 or on Middlebrook 7H10 agar (Difco) with 10% Middlebrook oleic acid/albumin/dextrose/catalase (OADC) enrichment (BBL) at 37ºC. Escherichia coli strain DH5α (32) was grown on Luria Bertani (LB) agar at 37ºC. The concentrations of antibiotics used were 25 µg mL -1 kanamycin and 50 µg mL -1 and 100 µg mL -1 hygromycin for M. bovis BCG and E. coli, respectively.
Construction of M. bovis bCG mutant strains
An unmarked deletion mutation in pimE (BCG_1220, homolog of Rv1159) was constructed in both M. bovis BCG wild-type as well as in M. bovis BCG ΔcapA (BCG_1673c, homolog of Rv1635c) which produces LAM devoid of mannose caps (5), using a two-step strategy involving vectors pGOAL19 and p2NIL (57) . First, two fragments harbouring the up-and downstream regions of pimE, respectively, were amplified by polymerase chain reaction (PCR) from M. bovis BCG genomic DNA using primer set BCG_1220-LF (5'-CTGGGCAAACTATTGGTGGT-3') and BCG_1220-LR (5'-CAGGTGATGATCCCGTCTTT-3') and primer set BCG_1220-RF (5'-CGATCGAGGGGTACATGAAG-3') and BCG_1220-RR (5'-CAGATAGGTCCAGGCGAGTC-3') using Pfu DNA polymerase (Fermentas). The temperature program was as follows: 94°C for 5 min, 30 cycles of 30 s at 96°C, 30 s at 56.5°C, and 2 min at 72°C, followed by 7 min at 72°C and subsequent cooling to 4°C. PCR products were cloned separately into pCRII-TOPO according to the manufacturer's instructions (Invitrogen). They were cut out using the EcoRI sites of pCRII-TOPO and ligated to each other in order to obtain the knockout pimE construct in which 771 basepairs of the gene were deleted. Constructs were checked for the correct orientation of the two fragments using primers BCG_1220-LR and BCG_1220-RF and re-cloned into pCRII-TOPO. A HinDIII/PstI digest from pCRII-TOPO-ΔpimE was ligated into HinDIII/PstI-digested p2NIL. A hyg -P Ag85 -lacZ -P hsp60 -sacB marker was cassette cut out from the pGOAL19 plasmid using PacI and subsequently cloned into the PacI site of p2NIL-ΔpimE to obtain the final plasmid, which was then electroporated into M. bovis BCG wild-type and the ΔcapA mutant (56) . Selection of mutants was performed as described previously (57) . In short, Kan R , Hyg R , Suc S , blue colonies were selected after single-cross-over events, which harbour both the wild-type pimE as well as a pimE gene with a deletion mutation, the hygromycin and kanamycin resistance genes (hyg and kan, respectively), lacZ, and sacB. Double-cross-over events were induced by selection on plates containing 2% (w/v) sucrose. Obtained colonies (Kan S , Hyg S , Suc R ) either contained a wild-type or mutant copy of pimE. Potential mutants were screened for the presence/absence of the deletion fragment by PCR using various primer sets.
Complementation of M. bovis bCG mutant strains
The pimE gene was amplified from genomic BCG DNA using primers BCG_1220-F-BamHI (5'-GGATCCGATGGTTGGCATGTCTCT-3') and BCG_1220-R (5'-AGGTGGTATCACGGAAAACG-3') using Pfu DNA polymerase (Fermentas). The following PCR program was used: 95°C for 3 min, 35 cycles of 30 s at 94°C, 30 s at 55°C, and 3 min at 72°C, followed by 7 min at 72°C. The obtained PCR product was cloned into pCRII-TOPO. This plasmid was digested with BamHI and Eco32I and the fragment was ligated into BamHI/Eco32I-digested pSMT3-eGFP (1, 33) . In the resulting plasmid, pSMT3-pimE, the pimE gene was located behind the heatshock promotor 60 (HSP60). pSMT3-pimE was isolated from E. coli DH5a cells using QIAprep Miniprep kit (Qiagen) and electroporated into M. bovis BCG ΔpimE as described (55) . Transformants were selected on hygromycin. For complementation of the M. bovis BCG ΔpimEΔcapA mutant, pimE was amplified using primers BCG_1220-F-BamHI and BCG_1220-R-BcuI (5'-ACTAGTAGGTGGTATCACGGAAAA-3') using the following PCR program: 95°C for 5 min, 35 cycles of 30 s at 94°C, 30 s at 58°C, and 3 min at 72°C, followed by 7 min at 72°C. The PCR product was cloned into pCRII-TOPO. The BamHI/BcuI digest of this plasmid was cloned into the BamHI/BcuI site of the plasmid pSMT3-capA (5) to obtain pSMT3-pimE-capA.
MAbs and DC-SIGN-Fc
Murine monoclonal antibodies (MAb) of the IgM class were used. MAb F30-5 recognizes the carbohydrate structure (Ara) 6 (for itsvstructure, see reference (42) ) and binds both ManLAM and AraLAM (5, 41) . MAb 55.92.1A1 binds the mannose cap on LAM (5). F183-24 recognizes α(1→2)-linked mannosyl residues as present in the mannose cap on ManLAM and PIM 6 (41) . The DC-SIGN-Fc construct consists of the extracellular portion of DC-SIGN C-terminally fused to a human IgG1-Fc fragment (25) . In all experiments involving DC-SIGN-Fc, Tris-buffered Saline containing 20 mM Tris, 150 mM NaCl, 1 mM MgCl 2 , 2 mM CaCl 2 (TSM) and 0.5% bovine serum albumin (BSA) (Fluka) was used instead of Phosphate Buffered Saline (PBS).
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PIMs 4 ) were prepared following methods published elsewhere (3) . A synthetic sample of The natural PIMs (natPIM 1,2 and natPIM 6 ) were purified from M. tuberculosis H37Rv and contained a mixture of differently acylated PIMs. The natPIMs were a gift from Colorado State University, USA.
SDS-PAGe and immunoblotting
M. bovis BCG was grown until mid/late-log phase and disrupted with a Beadbeater (BioSpec). Supernatants were equalized for protein content, as quantified by the BCA Protein Assay kit according to the manufacturer's instructions (Pierce). Cell lysates were run on a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel in a glycine buffer for immunostaining with MAb F30-5 or 55.92.1A1 or on a 12% SDS-PAGE gel in a tricine buffer for incubation with MAb F183-24 or DC-SIGN-Fc (44) . After transfer on a polyvinylidene fluoride (PVDF) membrane (Millipore) (68), the membrane was incubated in blocking reagens (Boehringer) followed by incubation with the MAbs. After washing, incubation with peroxidase (PO)-labeled goat-anti-mouse IgM (American Qualex) and 0.5% Normal Goat Serum (NGS) followed. Membranes probed with DC-SIGN-Fc were blocked with 1% BSA (Fluka) and goat-anti-human IgG-PO (Jackson Laboratories) in 0.5% NGS was used as secondary antibody (5, 6) . Membranes were developed using a mixture of 4-chloro-1-naphtol (Bio-Rad) and 3,3'-diaminobenzidine . 4HCl (Sigma-Aldrich).
DC-SIGN-Fc adhesion assay
SynPIMs and natPIMs were coated onto Enzyme-Linked ImmunoSorbent Assay (ELISA) plates (Nunc 96-well PolySorp) by adding methanol-dissolved PIMs (1 or 10 µg per well) and overnight evaporation to dryness at room temperature (RT). Titration of DC-SIGN-Fc (starting from 1.25 µg mL -1 ) was performed using the protocol as described for immunoblot with o-phenylenediamine dihydrochloride (Sigma-Aldrich) as the coloring reagent (27) . To verify proper coating of the PIMs on the ELISA plates, various concentrations of PIMs were coated and probed with monoclonal antibody HA-1A, which recognizes hydrophobic structures (34) . HA-1A bound to the less mannosylated PIMs similarly well as to PIM 6 . The median of the ratios in staining (measured by absorption at 490 nm) in nine data sets derived from three independent experiments was 0.9 for synPIM 2 /synPIM 6 , 1.1 for synPIM 4 /synPIM 6 and 0.9 for natPIM 1,2 /natPIM 6 .
Two-dimensional (2D) thin layer chromatography (TLC) for polar lipid analysis
Cells were harvested by centrifugation, washed once with PBS, and a small scale lipid extraction was performed to afford polar lipids as described previously (5, 10) . The extracts were resuspended in CHCl 3 :CH 3 OH (2:1) and crude lipids applied to the corners of aluminium backed TLC plates (Merck). The plates were developed in solvent system E for polar lipid extracts (10) . TLCs were run once in each direction using CHCl 3 :CH 3 OH:H 2 O (60:30:6) in the first direction and CHCl 3 :acetic acid:CH 3 OH:H 2 O (40:25:3:6) in the second. Lipids were visualized by staining with α-naphtol and brief charring at 100°C until lipids appeared, which could then be compared to known standards (10) .
Cells
Human peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats (Sanquin Bloodbank, NL) by centrifugation on a Ficoll-Paque gradient (GE Healthcare), followed by selection for CD14+ monocytes using anti-CD14 mAb-coupled magnetic beads and the Midi-MACS system (Miltenyi Biotech) (30) . Fresh monocytes were cultured in the presence of IL-4 (500 U mL -1 ) and GM-CSF (800 U mL -1 ) (PeproTech) to produce immature monocyte-derived DCs (MoDCs) (62), which were used for further experiments on day 6 after isolation. MoDCs, Raji cells, and transfected Raji cells expressing DC-SIGN (Raji + DC-SIGN cells) (24, 75) were cultured in RPMI 1640 (Gibco) supplemented with 10% fetal calf serum (Gibco), 100 units mL -1 penicillin, and 100 µg mL -1 streptomycin at 37°C and in a 5% CO 2 atmosphere.
binding of DC-SIGN to PIMs and M. bovis bCG as determined by flow cytometry
SynPIMs and natPIMs were coated onto 1.0 µm fluorescent beads (Polysciences #17154) by adding 50 µg PIMs to 1 mL 0.1 M carbonate-bicarbonate buffer (pH 9.6) containing 1.4 x 10 9 beads in pre-siliconized tubes (Sigma-Aldrich). After one hour rotating at 37°C, beads were collected by centrifugation and incubated for another hour in 1 mL 5% human serum albumin (HSA) (Sigma-Aldrich) in TSM and washed in 0.5% HSA in TSM (65) .
M. bovis BCG cultures were grown until mid-log phase, concentrated, and incubated with 1 mg mL -1 FITC (Sigma-Aldrich) for 15 min. at RT, after which the suspensions were washed and declumped by passaging through a 5 µm filter (Millipore).
Fluorescence of the different bead and mycobacterial suspensions was quantified using the FLUOstar-Galaxy microplate reader (BMG). Beads were added to human cells at a ratio of 50:1 and mycobacteria were added at a multiplicity of infection (MOI) of 0.5, 2 or 8. After an incubation of 45 minutes at 37ºC in absence or presence of 2 mg mL -1 mannan (Sigma-Aldrich), the percentage of fluorescent cells was determined using a FACScan Analytic Flow Cytometer (Becton Dickinson) and analyzed using manufacturer's software CellQuest version 3.1f.
Phagocytosis
MoDCs and mycobacteria were co-cultured at a MOI of 1-2 (in triplicates in each independent experiment) for 3 h at 37ºC after which amikacin (Sigma) was added to a concentration of 200 µg mL -1 for 2 h at 37ºC. Then the MoDCs were washed three times in PBS and finally lysed with 1% Triton X-100 (Sigma) in PBS for 20 minutes. Serial dilutions of the inoculum and the released mycobacteria were made in PBS + 0.05% Tween-80 and plated on 7H10-agar. Colony-forming units (CFU) were counted after 4 weeks (1).
Cytokine induction
MoDCs and mycobacteria were co-cultured for 24 h at 37ºC in absence or presence of 10 ng mL -1 lipopolysaccharide (LPS) from Salmonella enterica serotype abortus equi (Sigma-Aldrich). IL-10 and IL-12p40 concentrations in supernatants were analysed using an ELISA against human IL-10 and IL-12p40 according to the manufacturers' instructions (BioSource).
Statistical analysis
All values were expressed as means of triplicates ± standard deviation. The unpaired Student t test was used to identify differences between groups. A P value of < 0.05 was considered statistically significant.
reSultS

DC-SIGN has a higher affinity for PIM 6 as compared to less mannosylated PIMs
DC-SIGN exhibits a high affinity for α(1→2)-linked mannosyl residues (42) . As α(1→2)-linked mannosyl residues are present in polar PIMs, i.e. PIM 6 , but absent in apolar PIMs, i.e. PIM 4 , PIM 2 , and PIM 1 (Figure 1) , we set out to investigate the affinity of DC-SIGN for different species of PIMs using two independent assays. First, individual PIM compounds (both purified natPIMs and synPIMs) were coated onto ELISA-plates and probed with a DC-SIGN-Fc construct. As shown in Figure 2A , DC-SIGN-Fc strongly bound to both synPIM 6 and natPIM 6 , but not to synPIM 2 , synPIM 4 , and natPIM 1,2 (a mixture of PIM 1 and PIM 2 ), suggesting that DC-SIGN-Fc specifically recognized PIM 6 . To determine whether native, membrane-localized DC-SIGN exhibited a similar specificity, fluorescent polystyrene beads were coated with the different species of PIMs and assayed for the capacity to bind to MoDCs ( Figure 2B ) and Raji cells expressing DC-SIGN ( Figure S1 in the supplementary material). Consistent with the results for DC-SIGN-Fc, only the beads coated with PIM 6 (both natural and synthetic), as compared to the control beads coated with HSA, showed a significantly increased binding. The interaction could be blocked by the addition of mannan ( Figure  2B ) and by DC-SIGN-blocking antibody AZN-D1 ( Figure S2 ), confirming that binding was dependent on DC-SIGN. One representative experiment out of three (synPIMs) and two (natPIMs) is shown. This experiment was also repeated five and two times for the synPIMs and the natPIMs, respectively, using Raji + DC-SIGN cells ( Figure S1 ). *** is P < 0.0005; ** is P < 0.005; * is P < 0.05 compared to control HSA-beads.
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Construction of a M. bovis bCG pime mutant deficient for polar PIM production
As demonstrated above, DC-SIGN specifically bound to PIM 6. To study the role of PIM 6 in the interaction between DC-SIGN and whole mycobacteria, our next goal was to create a mutant strain deficient for the production of PIM 6 . Recently, it was demonstrated that pimE encodes the mannosyltransferase responsible for the elongation of PIM 4 to PIM 5 and that mutation of the gene abolished the production of polar PIMs (49) . Hence, we created a pimE knockout of M. bovis BCG. As PIM 6 may show redundancy with ManLAM in binding to DC-SIGN, we also constructed a double knockout deficient for both PIM 6 and the mannose caps on LAM (DpimEDcapA). First, the composition of PIMs in the cell wall of the wild-type and mutant strains was analyzed by 2D TLC. As shown in Figure 3 , all strains produced PIM 2 , yet PIM 6 was only present in the wild-type strain. In contrast, the mutant strains accumulated PIM 4 , which is consistent with the report on the mutation of the homologous gene in M. smegmatis mc 2 155 (49). Next, whole-cell lysates were probed on SDS-PAGE/immunoblot with MAb F183-24 which recognizes PIM 6 (unpublished data; A.H.J. Kolk) (Figure 4 ; lower left panel). In the low molecular weight part of the blot (< 14 kDa), which is the region harbouring the PIMs (39, 59), F183-24 bound to PIMs from wild-type M. bovis BCG and the complemented strains (Figure 4 ; lanes 1 and 6 and lanes 3 and 5, respectively), but not to PIMs from the mutant strains ΔpimE and ΔpimEΔcapA (lanes 2 and 4, respectively). As expected, since the LAM/PIM biosynthesis pathway bifurcates after PIM 4 (11, 43) 
binding of DC-SIGN-Fc to LAM and PIMs from wild-type M. bovis bCG and the Δpime and ΔpimeΔcapA mutant strains
To evaluate the consequences of the pimE and capA mutations for the recognition of LAM and PIMs by DC-SIGN-Fc, whole-cell lysates from the wild-type and mutant strains were analysed by tricine-SDS-PAGE followed by an immunoblot with DC-SIGN-Fc. As shown in Figure 4 
binding to DC-SIGN and phagocytic uptake of wild-type M. bovis bCG and the Δpime and ΔpimeΔcapA mutant strains
To determine the effect of the pimE and capA mutations for the binding of whole mycobacteria to DC-SIGN-expressing cells, the wild-type and mutant strains were tested for their ability to bind MoDCs using flow cytometry. As shown in Figure 5A , all three strains bound similarly well at all three MOIs tested. To test if a reduction in binding to DC-SIGN was possibly compensated for by other receptors on the MoDCs, the same assay was performed with Raji cells expressing DC-SIGN. As indicated in Figure 5B, the M. bovis BCG ΔpimE and ΔpimEΔcapA mutants showed a cell-binding pattern similar to that of the wild-type strain. Furthermore, the binding to MoDCs could be blocked by the addition of mannan ( Figure 5A ) and by DC-SIGN-blocking antibody AZN-D1 ( Figure S4 ), confirming that the interaction of the mutant strains with MoDCs was still dependent on DC-SIGN. Although in some experiments variation in binding was observed, binding of the mutant strains was never significantly lower. In contrast, in three out of six experiments, a 1.5-fold increase in binding of the mutant strains could be observed (data not shown). These data, together with the observation that the interactions could still be blocked by mannan suggests that even in the ΔpimEΔcapA double knockout additional ligands for DC-SIGN were present. Next, the wild-type and mutant strains were assayed for phagocytic uptake by MoDCs after three hours of co-culturing ( Figure S5) . A high variation in uptake efficiency was observed between the different donors. Nevertheless, the M. bovis BCG ΔpimEΔcapA mutant strain showed a consistent increase in phagocytic uptake as compared to the wild-type strain in five of the six experiments ( Figure S5 ). The median of the ratios (uptake of M. bovis BCG ΔpimEΔcapA) / (uptake of M. bovis BCG wild-type) was 2.2, which is in line with the increased binding of the mutant strain that was observed in the earlier binding studies. The data from the CFU count of the M. bovis BCG ΔpimE mutant strain were less consistent. For two donors the bacterial uptake was increased, whereas for the third donor it was lower ( Figure S5 ). Hence, drawing conclusions for this mutant strain was not possible. Figure S3 for the control binding assay with wild-type Raji cells. ***, P < 0.0005; **, P < 0.005; *, P < 0.05 compared to wild-type M. bovis BCG at equal MOIs.
Wild-type M. bovis bCG and the Δpime and ΔpimeΔcapA mutant strains induce a similar cytokine profile in MoDCs
DC-SIGN ligation interferes with TLR-signaling and enhances transcription of the IL-10 gene (27, 30) . In addition, it has been shown that purified ManLAM inhibits the production of IL-12 by human DCs (53) . Hence, removal of DC-SIGN ligands may induce an altered cytokine secretion profile in Mycobacterium-stimulated DCs. To determine the effect of the pimE and capA mutations on the ability to induce cytokine secretion in MoDCs, MoDCs (both immature and LPS-primed) were stimulated with the wild-type and mutant bacteria after which the amount of secreted IL-10 and IL-12p40 was determined. Although the Mycobacterium-induced cytokine secretion varied between the five different donors tested, no consistent differences within a single donor were observed. Nevertheless, in some experiments, such as the one shown in Figure 6 , significant differences at certain MOIs could be observed. In general, the mutant strains induced both more IL-12p40 as well as IL-10 ( Figure S9 ). Of note, in all five donors tested, both the immature and LPS-primed MoDCs produced IL-12p40 following stimulation. In contrast, IL-10 secretion was only observed for LPS-primed MoDCs. Since bioactive IL-12 consists of two subunits, i.e. IL-12p40 and IL-12-p35, with the p40 subunit also being present in other IL-12 family members, we also determined the amount of secreted IL-12p70. Although a difference in absolute Figure 6 . Induction of IL-10 (A) and IL-12p40 (B) secretion in MoDCs by M. bovis BCG. MoDCs were co-cultured with mycobacteria for 24 h in absence or presence of LPS after which cytokine secretion was measured by ELISA. Shown are means of triplicates and the standard deviation of one representative experiment (a total of five were conducted). IL-10 secretion by non-LPS activated MoDCs upon infection with BCG was below the detection level (<20 pg mL -1 ). ***, P < 0.0005; **, P < 0.005; *, P < 0.05 compared to wild-type M. bovis BCG at equal MOIs.
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cytokine production was observed, with the amount of secreted IL-12p40 being a factor 10 to 100 higher than IL-12p70 depending on donor, their relative induction was similar ( Figure S8 ). The ratios of (IL-12p40/IL-10 induced by M. bovis BCG ΔpimE) / (IL-12p40/IL-10 induced by wild-type M. bovis BCG) and of (IL-12p40/IL-10 induced by M. bovis BCG ΔpimEΔcapA) / (IL-12p40/IL-10 induced by wild-type M. bovis BCG) were calculated for LPS-primed MoDCs from four different donors (one donor did not produce IL-10). These ratios ranged from 0.66 to 1.33 (22 triplicate data sets) with a median of 1.01. Hence, we concluded that the IL-12p40/IL-10 ratios of the two mutant strains were identical to that of the wild-type strain, meaning that the absence of PIM 6 , either alone or in combination with missing mannose caps on LAM, did not alter the IL-12p40/IL-10 balance.
diScuSSion
In this study, we demonstrated that the degree of mannosylation, and in particular the presence of α(1→2)-linked mannosyl residues in the polar PIM 6 (Figure 1 ), determines the interaction of PIMs with DC-SIGN. DC-SIGN showed a high affinity for PIM 6 , but not for less mannosylated PIMs, including PIM 4 ( Figure 2 ). Yet, a mutant strain, deficient in the production of polar PIMs, bound equally well to DC-SIGN as wild-type M. bovis BCG ( Figure 5 ). Even a double mutant, which was also devoid of mannose caps on LAM, did not bind less to DC-SIGN and DCs. Binding of the mutant strains could still be blocked by mannan, indicating that additional DC-SIGN ligands were present.
It has been suggested that mycobacteria target DC-SIGN to escape immune surveillance (26, 69) . However, studies investigating single nucleotide polymorphisms in the promotor region of DC-SIGN have shown a reduced risk of TB associated with both down-regulation of DC-SIGN expression (70) as well as up-regulation (7) or even no association with susceptibility to TB at all (9, 29) . A study with mice lacking SIGNR1 -one of the murine homologs for DC-SIGN -showed that these mice had stronger T helper 1 responses to M. tuberculosis and a reduced level of IL-10 (72). However, no differences in bacterial load and mouse survival rates could be detected (72) . In a recent publication on human DC-SIGN transgenic mice, a decreased pathology and prolonged survival during mycobacterial infection have been reported. In this case no differences in IL-10 secretion could be detected (64) . It should be taken into account that the murine DC-SIGN system is different from the human one in both expression and specificity and it is not known yet which homolog is functionally most similar to the human DC-SIGN version (58, 60) . Hence, many questions regarding the functional consequences of the interaction between mycobacteria and DC-SIGN still exist (51) .
Mycobacterial strains that show a reduced binding to DC-SIGN will help to elucidate the role of DC-SIGN in mycobacterial pathogenesis. In principle, such strains can be developed by deleting the major DC-SIGN ligand(s) present. In contrast to what has long been thought, deletion of the mannose cap on LAM did not abrogate the DC-SIGN-mycobacterial interaction (5). Polar PIMs, i.e. PIM 5 and PIM 6 , have been proposed before as possible ligands for DC-SIGN (67) . Although it was shown that the degree of PIM mannosylation did not determine its binding to DC-SIGN (67), we decided to reconsider the case for two separate reasons. Firstly, DC-SIGN shows a unambiguous high affinity of for α(1→2)-interlinked mannosyl residues and this affinity increases with number of mannosyl residues present, suggesting that DC-SIGN, in theory, should display an increased affinity towards higher order PIMs (20, 42) and secondly, because previous studies on PIMs were only performed with purified or synthetic compounds and not with whole mycobacteria.
In two independent assay systems with (i) ELISA plates coated with different species of PIMs and probing with DC-SIGN-Fc and (ii) PIM-coated beads used in binding studies with DC-SIGN expressing cells, we observed a clear difference in the affinity of DC-SIGN for the individual species of PIMs ( Figure 2 ); only PIM 6 was recognized by DC-SIGN. Even at high concentrations (10 µg per well with ELISA) or at high bead to cell ratios (100:1; data not shown), we did not detect significant binding of DC-SIGN to synPIM 2 , synPIM 4 or natPIM 1, 2 . Whether the degree and nature of PIM acylation played a role in their binding to DC-SIGN was not directly assessed. However, these data suggest this is not important because the synPIMs that were all diacylated with identical fatty acids and were single discrete species, displayed similar binding properties to the analogous natPIMs that contained mixtures of mono-to tetra-acylated PIMs. Moreover, natPIM 6 and synPIM 6 both showed a high affinity for DC-SIGN indicating that differences in affinity are directly related to the degree of mannosylation. Strikingly, our results are different from those reported by Torrelles et al. (67) . In that study, it was demonstrated that all PIMs, irrespective of their degree of mannosylation, showed a similar binding to DC-SIGN. We have no ready explanation for the difference in outcome, however, we do note that the magnitude of the binding reported for PIMs to DC-SIGN in the study by Torelles et al. was very small for all species tested and thus lacked specificity. Our data are more in agreement with a recent study by Boonyarattanakalin and co-workers (12) . This study on the chemical synthesis of PIMs showed a high affinity of DC-SIGN for the polar PIMs, i.e PIM 5 and PIM 6 , and a low or no affinity for the less mannosylated PIMs, i.e. PIM 2 and PIM 4 , respectively, in a fluorescent scanning assay of a PIM microarray.
The M. bovis BCG ΔpimE and ΔpimEΔcapA mutant strains were created to investigate the role of polar PIMs in the interaction between DC-SIGN and whole mycobacteria. Although polar PIMs have been reported to be essential for cell wall integrity and mycobacterial growth (31) , no differences in growth between the mutant and the parent strain were observed ( Figure S6 ), except for a higher tendency of the mutant strains to clump in older cultures (> 1½ week) at high OD 600 (data not shown). Interestingly, the M. bovis BCG ΔpimE and ΔpimEΔcapA mutant strains accumulated PIM 4 , a feature which was not observed for wild-type M. bovis BCG. This confirms that in wild-type M. bovis BCG PIM 4 is an intermediate in polar PIM biosynthesis (28).
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The M. bovis BCG ΔpimE and ΔpimEΔcapA mutant strains did not show apparent phenotypic changes other than the altered production of PIM 6 and the mannose caps on LAM. Since DC-SIGN specifically bound PIM 6 in vitro (Figure 2) , we hypothesized that deletion of PIM 6 may reduce mycobacterial binding to cells expressing DC-SIGN. To test this, we first compared the binding of wild-type and mutant bacteria to MoDCs. The results indicated that both M. bovis BCG ΔpimE and ΔpimEΔcapA bound as well to MoDCs as the wild-type strain ( Figure 5A ). To exclude that other receptors on MoDCs masked a reduced affinity of DC-SIGN for the mutant strains, binding of the wild-type and mutant strains to Raji cells expressing DC-SIGN was also assessed. Also in this case, no reduction and in some cases even a small increase in binding of the mutant strains as compared to the wild-type strain was observed ( Figure 5B ). This latter finding could be due to a less hydrophobic cell surface of the mutant strains, as was reported for M. smegmatis ΔpimE mutant (49) , since the increased binding was also observed for the wild-type Raji cells that do not express DC-SIGN ( Figure S3 ). Binding of the mutant strains to MoDCs could still be blocked by mannan ( Figure 5 ) as well as by DC-SIGN-blocking antibody AZN-D1 ( Figure S4 ). Therefore, we conclude that the absence of PIM 5 and PIM 6 in the mutant strains did not alter receptor usage for MoDCs: DC-SIGN was still the major receptor.
Finally, wild-type M. bovis BCG and the ΔpimE and ΔpimEΔcapA mutant strains were assayed for their ability to induce IL-12p40 and IL-10 secretion by MoDCs. The balance between IL-10 and IL-12 is important for shaping the host immune response and alterations in it may thus influence the outcome of mycobacterial infections (4, 37, 50) . Binding to DC-SIGN enhances transcription of IL10 upon TLR signaling (30) . Furthermore, PIMs have been reported to suppress allergic airway disease, which is associated with an increased production of IL-10 (2, 63). However, in the latter two studies PIM 1 and PIM 2 were used (2, 63), and IL-10 induction in this case likely involves a different pathway (22) . In our experiments, in which LPS-primed MoDCs were cocultured with wild-type M. bovis BCG, or the ΔpimE and ΔpimEΔcapA mutant strains, no decrease in IL-10 secretion by MoDCs incubated with the mutant strains compared to wild-type M. bovis BCG was found ( Figure 6A ). Instead, there was a tendency of higher cytokine induction (for IL-10, IL-12p40, and IL-12p70) by the mutant strains as compared to wild-type M. bovis BCG (Figure S8 and S9) . However, because the mutant strains induced a higher production of both anti-inflammatory IL-10 and pro-inflammatory IL-12p40, the increased cytokine production is probably not of biologically significance. Importantly, it should be noted that the IL-10 induction by mycobacteria alone could not be detected. Only after co-stimulation with LPS did M. bovis BCG induce the secretion of IL-10. Since mycobacteria do not contain LPS, although other TLR4 ligands may be present (18) , it will be important to investigate DC-SIGN-dependent IL-10 induction also with other classes of TLR ligands (particularly TLR2).
In summary, we have shown that although DC-SIGN has a high affinity for PIM 6 , this glycolipid does not dictate the Mycobacterium-DC-SIGN interaction. This finding demonstrates, like our previous study (5) , that the interaction of mycobacteria with DC-SIGN is much more complex than initially anticipated. Furthermore, it demonstrates that studies with purified compounds should be interpreted with great care. In addition, our study shows that mycobacteria do not express one or two but probably many more ligands for DC-SIGN. As can be seen in Figure 4 (lower right panel), DC-SIGN-Fc recognized, besides ManLAM and PIM 6 , many additional bands (lane 4). These bands most likely represent mannosylated proteins, which are known to be expressed by mycobacteria (19) . For at least the 45-kDa glycoprotein it has been reported that the mannobiose and mannotriose units present are all α(1→2)-linked and thus reminiscent of the mannose cap on ManLAM (17) . If these proteins are indeed involved in the binding of mycobacteria to DC-SIGN, creation of mutant strains displaying a reduced binding will be a huge task to perform. It will therefore be of great importance to evaluate the role of mannosylated proteins for the binding of mycobacteria to DC-SIGN. Figure S1 . Binding assay with Raji cells and Raji + DC-SIGN cells. Cells were incubated with beads coated with synthetic and purified phosphatidylinositol mannosides (synPIMs and natPIMs, respectively) at a multiplicity of infection (MOI) of 50 for 45 minutes at 37°C. Percentage of the cell population binding PIM-coated beads was measured using flow cytometry and compared to beads incubated only in human serum albumin (HSA). Shown are means of triplicates and standard deviation. One representative experiment out of five (synPIMs) and two (natPIMs) is shown. These experiments were performed in addition to the binding experiments with dendritic cells (DCs) as described in article ( Figure 2B ). *** is P < 0.0005; ** is P < 0.005; * is P < 0.05 compared to control HSA-beads. Figure S2 . Binding assay with dendritic cells (MoDCs). MoDCs were pre-incubated with 50 µg mL -1 DC-SIGN-blocking antibody AZN-D1 (5) or 2 mg mL -1 mannan for 30 minutes followed by incubation with beads coated with natPIMs at a MOI of 50 for 45 minutes at 37°C. Percentage of the cell population binding PIM-coated beads was measured using flow cytometry. Shown are means of triplicates and standard deviation. *** is P < 0.0005; ** is P < 0.005 compared to control HSA-beads (plus medium). One representative experiment out of three is shown. These experiments were performed simultaneously with the binding experiments on Raji + DC-SIGN cells as described in article ( Figure 5 ). ** is P < 0.005; * is P < 0.05 compared to wild-type BCG strain at equal MOI. . Two dimensional thin-layer chromatography (2D-TLC) apolar lipid profile of M. bovis BCG wild-type, ΔpimE and ΔpimEΔcapA. Cells were harvested by centrifugation, washed once with phosphate buffered saline (PBS) and a small scale lipid extraction performed as described to afford apolar lipids (2) . The apolar lipid extracts were resuspended in CHCl 3 :CH 3 OH (2:1) and crude lipids applied to the corners of 6.6 x 6.6 cm pieces of Merck 5554 aluminium backed TLC plates. The plates were developed in a series of solvent systems, designed to cover the whole range of lipid polarities as described (2) . For apolar lipid extracts these systems were named systems A-D and for polar lipid extracts; system E. System A TLCs were run thrice in direction 1 (petroleum ether 60-80: ethyl acetate 98:2) and once in direction 2 (petroleum ether 60-80: acetone 98:2). System B TLCs were run thrice in direction 1 (petroleum ether 60-80: acetone 92:8) and once in direction 2 (toluene: acetone 95:5). Petroleum ether/acetone (92:8). Systems C and D TLCs were run once in each direction using, for system C CHCl 3 :CH 3 OH (96:4) in the first direction and toluene: acetone (80:20) in the second, and for system D CHCl 3 :CH 3 OH:H 2 O (100:14:0.8) in the first direction and chloroform: acetone:CH 3 OH:H 2 O (50:60:2.5:3) in the second. System E TLCs are described in the article. Lipids were visualized by staining with 5% molybdophosphoric acid in ethanol and briefly charring plates at 100°C until lipids appeared and compared to know standards (2) . PDIM is phtiocerol dimycocerosate; MK is menaquinone; DAG is diaglycerol; PGL is phenolic glycolipid; TMM is trehalose monomycolate; TDM is trehalose dimycolate; GMM is glucose monomycolate. phosphatiDyliNositol maNNosiDes iN MyCobACTerIuM-host iNteractioN MoDCs were co-cultured with mycobacteria for 24 h in absence or presence of LPS after which cytokine secretion was measured by ELISA. Shown are means of triplicates and the standard deviation of one representative experiment (a total of five were conducted). *** is P < 0.0005; ** is P < 0.005; * is P < 0.05 compared to wild-type M. bovis BCG at equal MOIs. figure C) . The ratios of (IL-12p40/IL-10 induced by the mutant strains) / (IL-12p40/IL-10 induced by the wild-type strain) were also calculated for LPS-primed MoDCs from four different donors (the donor that did not produce IL-10 was excluded). These ratios ranged from 0.66 to 1.33 (22 triplicate data sets) with a median of 1.01.
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